Palette Life Sciences Launches Barrigel Center of Excellence Program Designations

Recognizing Exceptional Institutions and Professionals in Barrigel Research and Innovation

Palette Life Sciences, a fully-integrated global life sciences company dedicated to improving patient outcomes, today announced the new Barrigel Center of Excellence Program designations for May. Palette Life Sciences is a fully integrated life sciences company. Palette Life Sciences’ products improve patient outcomes in urology and urogynecology disorders, colorectal conditions, radiotherapy, and interventional oncology procedures. The company’s portfolio of available products includes Barrigel, Deflux, Solesta, and Lidbree. Palette Life Sciences moves rapidly to leverage novel applications of existing technologies to create breakthrough medical solutions. This focus enables the company to serve those often overlooked by traditional medical companies and improve patient quality of life. Led by experienced healthcare executives, Palette Life Sciences is headquartered in Stockholm, Sweden, with offices in Santa Barbara, California; Dallas, Texas; Sydney, Australia; and Tokyo, Japan.

The program recognizes doctors who have achieved exceptional clinical expertise in the Barrigel procedure and are steadfast in their dedication to patient education and improving outcomes of prostate cancer radiotherapy. Physicians and their institutions designated as a Barrigel Center of Excellence have completed additional advanced technique training and demonstrated a high degree of procedure skill and experience.

Palette Life Sciences is pleased to designate these outstanding institutions and physicians as Barrigel Centers of Excellence based on their commitment to minimizing the side effects of prostate radiation therapy and delivering the gold standard for prostate cancer treatment,” said Travis Gay, Chief Commercial Officer at Palette Life Sciences. “Together, our mission is to improve the quality of life for men with prostate cancer following radiation exposure and strive to deliver the best possible care for patients.

Barrigel is the first and only hyaluronic acid rectal spacer that separates the prostate from the rectum to protect the rectum during radiation therapy treatment for prostate cancer. It has been proven to significantly reduce unwanted side effects from prostate cancer radiation therapy.

Published on : 31st May, 2023